632 related articles for article (PubMed ID: 15585487)
1. 99mTc-N-DBODC5, a new myocardial perfusion imaging agent with rapid liver clearance: comparison with 99mTc-sestamibi and 99mTc-tetrofosmin in rats.
Hatada K; Riou LM; Ruiz M; Yamamichi Y; Duatti A; Lima RL; Goode AR; Watson DD; Beller GA; Glover DK
J Nucl Med; 2004 Dec; 45(12):2095-101. PubMed ID: 15585487
[TBL] [Abstract][Full Text] [Related]
2. Organ biodistribution and myocardial uptake, washout, and redistribution kinetics of Tc-99m N-DBODC5 when injected during vasodilator stress in canine models of coronary stenoses.
Hatada K; Ruiz M; Riou LM; Lima RL; Goode AR; Watson DD; Beller GA; Glover DK
J Nucl Cardiol; 2006 Nov; 13(6):779-90. PubMed ID: 17174809
[TBL] [Abstract][Full Text] [Related]
3. [Myocardial perfusion imaging with [(99m)Tc (N) (PNP5) (DBODC)](+) in canine model of acute myocardial ischemia].
Zhang WC; Fang W; Wang XB; Li B; Tang ZG; Guo F; Guo L; Geng QH; He ZX
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Oct; 35(10):949-55. PubMed ID: 18206048
[TBL] [Abstract][Full Text] [Related]
4. Myocardial technetium-99m-tetrofosmin and technetium-99m-sestamibi kinetics in normal subjects and patients with coronary artery disease.
Münch G; Neverve J; Matsunari I; Schröter G; Schwaiger M
J Nucl Med; 1997 Mar; 38(3):428-32. PubMed ID: 9074532
[TBL] [Abstract][Full Text] [Related]
5. Experimental study of [99mTc(PNP5) (DBODC)]+ as a new myocardial perfusion imaging agent.
Zhang WC; Fang W; Li B; Wang XB; He ZX
Cardiology; 2009; 112(2):89-97. PubMed ID: 18583906
[TBL] [Abstract][Full Text] [Related]
6. 99mTc-N-DBODC5: a novel myocardial perfusion imaging agent for diagnosis of coronary artery disease, a review.
Takeda T; Wu J; Lwin TT
Recent Pat Cardiovasc Drug Discov; 2006 Jun; 1(2):161-6. PubMed ID: 18221083
[TBL] [Abstract][Full Text] [Related]
7. Comparison of ⁹⁹mTc-N-DBODC5 and ⁹⁹mTc-MIBI of myocardial perfusion imaging for diagnosis of coronary artery disease.
Ma H; Li S; Wu Z; Liu J; Liu H; Guo X
Biomed Res Int; 2013; 2013():145427. PubMed ID: 23841052
[TBL] [Abstract][Full Text] [Related]
8. Tc-99m-N-MPO: novel cationic Tc-99m radiotracer for myocardial perfusion imaging.
Kim YS; Wang J; Broisat A; Glover DK; Liu S
J Nucl Cardiol; 2008; 15(4):535-46. PubMed ID: 18674722
[TBL] [Abstract][Full Text] [Related]
9. Technetium-99m-tetrofosmin in dipyridamole-stress myocardial SPECT imaging: intraindividual comparison with technetium-99m-sestamibi.
Flamen P; Bossuyt A; Franken PR
J Nucl Med; 1995 Nov; 36(11):2009-15. PubMed ID: 7472590
[TBL] [Abstract][Full Text] [Related]
10. Rapid hepatic clearance of 99mTc-TMEOP: a new candidate for myocardial perfusion imaging.
Goethals LR; Santos I; Caveliers V; Paulo A; De Geeter F; Lurdes PG; Fernandes C; Lahoutte T
Contrast Media Mol Imaging; 2011; 6(4):178-88. PubMed ID: 21861278
[TBL] [Abstract][Full Text] [Related]
11. Comparative myocardial uptake of technetium-99 m sestamibi and technetium-99m tetrofosmin one hour after stress injection.
Gremillet E; Champailler A
Eur J Nucl Med; 1998 Nov; 25(11):1502-10. PubMed ID: 9799346
[TBL] [Abstract][Full Text] [Related]
12. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
Lind P; Gallowitsch HJ
Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biologic evaluation of monocationic asymmetric 99mTc-nitride heterocomplexes showing high heart uptake and improved imaging properties.
Boschi A; Uccelli L; Bolzati C; Duatti A; Sabba N; Moretti E; Di Domenico G; Zavattini G; Refosco F; Giganti M
J Nucl Med; 2003 May; 44(5):806-14. PubMed ID: 12732683
[TBL] [Abstract][Full Text] [Related]
14. Efficiency comparison between 99m Tc-tetrofosmin and 99m Tc-sestamibi myocardial perfusion studies.
Ravizzini GC; Hanson MW; Shaw LK; Wong TZ; Hagge RJ; Pagnanelli RA; Jain D; Lima HS; Coleman RE; Borges-Neto S
Nucl Med Commun; 2002 Mar; 23(3):203-8. PubMed ID: 11891477
[TBL] [Abstract][Full Text] [Related]
15. Whole-body biodistribution and radiation dosimetry of the new cardiac tracer 99mTc-N-DBODC.
Cittanti C; Uccelli L; Pasquali M; Boschi A; Flammia C; Bagatin E; Casali M; Stabin MG; Feggi L; Giganti M; Duatti A
J Nucl Med; 2008 Aug; 49(8):1299-304. PubMed ID: 18632816
[TBL] [Abstract][Full Text] [Related]
16. Myocardial uptake characteristics of three 99mTc-labeled tracers for myocardial perfusion imaging one hour after rest injection.
Manka-Waluch A; Palmedo H; Reinhardt MJ; Joe AY; Manka C; Guhlke S; Biersack HJ; Bucerius J
Ann Nucl Med; 2006 Dec; 20(10):663-70. PubMed ID: 17385304
[TBL] [Abstract][Full Text] [Related]
17. Biological in vitro and in vivo studies of a series of new asymmetrical cationic [99mTc(N)(DTC-Ln)(PNP)]+ complex (DTC-Ln = alicyclic dithiocarbamate and PNP = diphosphinoamine).
Bolzati C; Cavazza-Ceccato M; Agostini S; Refosco F; Yamamichi Y; Tokunaga S; Carta D; Salvarese N; Bernardini D; Bandoli G
Bioconjug Chem; 2010 May; 21(5):928-39. PubMed ID: 20402465
[TBL] [Abstract][Full Text] [Related]
18. Monocationic radiotracer kinetics and myocardial infarct size: a perfused rat heart study.
Okada DR; Liu Z; Beju D; Okada RD; Johnson G
Ann Nucl Med; 2008 Aug; 22(7):617-27. PubMed ID: 18756365
[TBL] [Abstract][Full Text] [Related]
19. Influence of the different biokinetics of sestamibi and tetrofosmin on the interpretation of myocardial perfusion imaging in daily practice.
Hambÿe AS; Delsarte P; Vervaet AM
Nucl Med Commun; 2007 May; 28(5):383-90. PubMed ID: 17414888
[TBL] [Abstract][Full Text] [Related]
20. Technetium-99m-tetrofosmin to assess myocardial blood flow: experimental validation in an intact canine model of ischemia.
Sinusas AJ; Shi Q; Saltzberg MT; Vitols P; Jain D; Wackers FJ; Zaret BL
J Nucl Med; 1994 Apr; 35(4):664-71. PubMed ID: 8151391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
